Back

Epicardial fat increase over time after lung transplantation

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Calcium, pericoronary fat, and epicardial fat Morphology, Dimensions, Volumes and Mass ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Britt Van Dijk

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Long-term prognostic implications of pericoronary inflammation assessed by pre-interventional computed tomography in patients with non-ST-segment elevation acute coronary syndrome
Doctor K. Sayama (Tsuchiura, JP)
Abstract Slides Video
Presentation thumbnail
Planimetry in aortic valve stenosis using computed tomography angiography - cut-off determination
Doctor S. Voegele (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
Pericoronary adipose tissue attenuation assessed by ultra-high-resolution CT post COVID-19
Doctor B. Romanelli Scarpa Matuck (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Coronary calcium score in primary prevention: clinical characteristics and segmental distribution from an Argentine clinic registry.
Mrs P. Kuschnir (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Epicardial fat: a non-invasive, non-contrast imaging biomarker for high-risk plaque monitoring
Doctor J. Henzel (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Calcium, pericoronary fat, and epicardial fat

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue alterations as a potential driver in the transition from obesity to heart failure with preserved ejection fraction
thumbnail
Congress Presentation
The role of epicardial fat in patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources